Rigel Pharmaceuticals, Inc. earnings per share and revenue

RIGL earnings per share for the last quarter are 0.80 USD whereas the estimation was 0.45 USD which accounts for 77.48% surprise. Company revenue for the same period amounts to 57.60 M USD despite the estimated figure of 50.10 M USD. Estimated earnings per share for the next quarter are 0.20 USD, and revenue is expected to reach 46.09 M USD. Also watch annual changes over time to get a bigger picture of RIGL earnings per share and revenue dynamics.